ZDHHC12 (Zinc Finger DHHC-Type Containing 12)
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | ZDHHC12 |
| Full Name | Zinc Finger DHHC-Type Containing 12 |
| Chromosomal Location | 9q34.3 |
| NCBI Gene ID | 197407 |
| OMIM ID | 614539 |
| Ensembl ID | ENSG00000159593 |
| UniProt ID | Q9NPA8 |
| Encoded Protein | Zinc Finger DHHC-Type Containing 12 |
| Protein Family | DHHC palmitoyltransferase family |
| Protein Length | 360 amino acids |
| Molecular Weight | ~41 kDa |
| Associated Diseases | Intellectual Disability, Cerebellar Ataxia, Neurodevelopmental Disorders |
</div>
Overview
ZDHHC12 encodes a member of the zinc finger DHHC-type palmitoyltransferase (PAT) family, a group of enzymes that catalyze the S-acylation (palmitoylation) of proteins. Palmitoylation is a reversible lipid modification that plays critical roles in regulating protein localization, stability, trafficking, and function within the nervous system[@fukata2008].
The ZDHHC (zinc finger DHHC) family consists of 23 members in humans (ZDHHC1-24), each characterized by a conserved DHHC domain (Asp-His-His-Cys motif) that serves as the catalytic core for palmitoyltransferase activity. ZDHHC12 is one of several brain-enriched ZDHHC enzymes that play essential roles in neuronal development, synaptic function, and potentially neurodegeneration.
Palmitoylation differs from other lipid modifications (myristoylation, prenylation) in being reversible, allowing dynamic regulation of protein-membrane associations in response to cellular signals. This reversibility is particularly important in neurons, where synaptic plasticity requires rapid changes in protein localization and function.
Gene Structure and Evolution
The ZDHHC12 gene is located on chromosome 9q34.3, spanning approximately 8.5 kilobases. The gene consists of 6 exons encoding a 360-amino acid protein with a calculated molecular weight of approximately 41 kDa.
ZDHHC12 is evolutionarily conserved across vertebrates:
- Mus musculus (mouse) — 89% amino acid identity
- Danio rerio (zebrafish) — 78% identity
- Xenopus laevis (frog) — 82% identity
- Drosophila melanogaster (fruit fly) — 61% identity
The conservation of ZDHHC12, particularly in the DHHC domain, indicates fundamental importance in cellular function across species.
Protein Structure and Function
DHHC Domain Architecture
The ZDHHC12 protein contains the characteristic DHHC motif (Asp-His-His-Cys) within a Cys-rich domain that forms the catalytic center of palmitoyltransferases. The domain structure includes:
N-terminal regulatory domain — Contains multiple predicted transmembrane regions
DHHC domain — Catalytic core (residues 140-180)
C-terminal regulatory region — Contains sites for potential regulatory interactionsThe enzymatic mechanism involves:
Acyl-CoA binding — The enzyme binds palmitoyl-CoA as the acyl donor
Substrate recognition — The target protein's N-terminal cysteine is positioned for modification
Thioester formation — A reversible thioester intermediate forms between the enzyme and the fatty acid
Acyl transfer — The fatty acid is transferred to the target cysteineSubstrate Specificity
ZDHHC12 has been shown to palmitoylate several neuronal proteins, including:
- Synaptic proteins — Components of the synaptic vesicle cycle
- Receptor proteins — G-protein coupled receptors and ion channels
- Scaffold proteins — Postsynaptic density components
- Enzymes — Signaling molecules and metabolic enzymes
The substrate specificity of ZDHHC12 suggests specialized functions in:
- Synaptic vesicle trafficking
- Receptor signaling at the synapse
- Neuronal development and migration
Role in Neuronal Function
Synaptic Transmission
Palmitoylation plays critical roles in synaptic function through dynamic regulation of protein localization at synaptic sites[@el Husseini2002]. ZDHHC12 contributes to:
Synaptic vesicle dynamics: Palmitoylation regulates proteins involved in vesicle fusion, release, and recycling
Receptor trafficking: GPCRs and ion channels require palmitoylation for proper synaptic localization
Scaffold protein localization: PSD95 and related scaffolding proteins are palmitoylatedKey synaptic proteins regulated by ZDHHC12 family members include:
- Synaptophysin: Major synaptic vesicle protein
- Synapsin: Regulates synaptic vesicle reserve pool
- PSD-95: Postsynaptic density scaffolding protein
- GABAB receptors: Metabotropic GABA receptors[@stowers2015]
Neuronal Development
ZDHHC12 is expressed during critical periods of brain development and influences:
Neuronal migration: Palmitoylation affects proteins involved in cytoskeletal dynamics
Axon guidance: Growth cone proteins require proper palmitoylation for correct targeting
Dendrite morphogenesis: Branching and spine formation involve palmitoylated proteins
Synapse formation: Pre- and post-synaptic specializations require precise protein localizationThe developmental expression pattern of ZDHHC12 suggests essential functions in:
- Cortical neuronal development
- Cerebellar maturation
- Hippocampal circuit formation
Neural Cell Adhesion
Palmitoylation of neural cell adhesion molecules (NCAM) regulates:
- Neuronal migration
- Axon fasciculation
- Synapse formation and plasticity[@hershko2013]
ZDHHC12-mediated palmitoylation influences the trafficking and function of adhesion molecules at developing synapses.
Role in Neurodegenerative Diseases
Alzheimer's Disease
Palmitoylation dynamics are significantly altered in Alzheimer's disease, affecting multiple pathological pathways[@emamzadeh2016]:
Amyloid Precursor Protein (APP) Processing
- ZDHHC family members palmitoylate APP and influence its trafficking
- Palmitoylation affects APP localization to lipid rafts, where amyloidogenic processing occurs
- Altered palmitoylation may contribute to increased Aβ production[@li2016]
Tau Pathology
- Palmitoylation of tau protein has been reported in AD brains
- S-acylation affects tau's ability to bind microtubules
- Palmitoylated tau may have altered aggregation properties[@r不正2018]
Synaptic Dysfunction
- Loss of synaptic proteins is an early hallmark of AD
- Synaptic proteins are dynamically palmitoylated; this cycle is disrupted in AD
- ZDHHC enzymes may be therapeutic targets to restore synaptic function[@yanai2021]
Parkinson's Disease
Connections between ZDHHC12 and Parkinson's disease include:
Alpha-synuclein palmitoylation: Some studies suggest α-synuclein may be palmitoylated
Dopaminergic neuron survival: Palmitoylation affects neuronal viability
Mitochondrial function: ZDHHC enzymes regulate mitochondrial protein functionHuntington's Disease
Palmitoylation is implicated in Huntington's disease through[@chen2020]:
Mutant huntingtin palmitoylation: Altered palmitoylation of mutant protein
Synaptic dysfunction: Palmitoylation of synaptic proteins disrupted
Neuronal vulnerability: Palmitoyltransferase activity affects survivalNeurodevelopmental Disorders
ZDHHC12 mutations cause a novel neurodevelopmental syndrome characterized by[@glatz2019]:
- Intellectual disability: Varying degrees of cognitive impairment
- Cerebellar ataxia: Coordination deficits and gait instability
- Speech delay: Language development abnormalities
- Behavioral features: Autism spectrum traits in some patients
This syndrome highlights the critical role of protein palmitoylation in normal brain development and function.
Expression Patterns
Tissue Distribution
ZDHHC12 shows highest expression in neural tissues:
| Tissue | Expression Level |
|--------|-----------------|
| Brain (cerebral cortex) | High |
| Cerebellum | High |
| Hippocampus | High |
| Spinal cord | Moderate |
| Testis | Low to moderate |
| Heart | Very low |
| Liver | Very low |
CNS Cell Type Expression
Within the brain, ZDHHC12 is expressed in:
- Neurons: High expression in pyramidal neurons and interneurons
- Astrocytes: Moderate expression
- Oligodendrocytes: Lower expression
- Microglia: Very low expression
Developmental expression peaks during:
- Embryonic cortical development
- Postnatal synaptogenesis
- Adolescent brain maturation
Brain Region Specificity
| Region | Expression Level | Cell Types |
|--------|-----------------|------------|
| Cerebral Cortex | High | Pyramidal neurons, interneurons |
| Hippocampus | High | CA1-CA3 pyramidal cells, dentate granule cells |
| Cerebellum | High | Purkinje cells, granule cells |
| Basal Ganglia | Moderate | Medium spiny neurons |
| Thalamus | Moderate | Relay neurons |
| Brainstem | Moderate | Various nuclei |
Cellular and Subcellular Localization
Within neurons, ZDHHC12 localizes to:
Endoplasmic reticulum (ER): Primary site of palmitoylation reactions
- Rough ER in neuronal soma
- ER compartments in dendrites and axons
Golgi apparatus: Processing and trafficking of palmitoylated proteins
- Cis-Golgi network
- Trans-Golgi network
Dendritic compartments:
- Dendritic shafts
- Dendritic spines (postsynaptic)
- Spine apparatus
Axonal compartments:
- Axon initial segment
- Synaptic vesicle membranes
- Presynaptic terminals
Activity-Dependent Regulation
ZDHHC12 expression and activity are modulated by neuronal activity:
- Calcium signaling: Activity-dependent upregulation
- Glutamate stimulation: Increases ZDHHC12 expression
- Depolarization: Rapid changes in localization
- Learning paradigms: Activity-induced changes in hippocampus
Signaling Pathways
Mermaid diagram (expand to render)
Therapeutic Implications
Drug Development Targets
The palmitoylation machinery represents a potential therapeutic target for neurodegenerative diseases:
Palmitoyltransferase inhibitors: Selective inhibitors of specific ZDHHC enzymes
Acyltransferase modulators: Compounds that enhance or inhibit specific activities
Substrate analogs: Modified substrates that compete with endogenous targetsChallenges
- Specificity: Achieving selectivity for individual ZDHHC enzymes is challenging
- Pleiotropic effects: Palmitoylation affects many proteins simultaneously
- Blood-brain barrier: Therapeutic agents must cross into the CNS
Research Directions
Current research focuses on:
- Developing selective ZDHHC12 inhibitors
- Understanding substrate specificity
- Identifying disease-specific palmitoylation changes
- Exploring gene therapy approaches
Therapeutic Strategies
Small Molecule Approaches
| Strategy | Target | Status | Challenges |
|----------|--------|--------|------------|
| Direct inhibitors | ZDHHC12 catalytic site | Preclinical | Specificity |
| Allosteric modulators | Protein-protein interface | Early discovery | Binding affinity |
| Substrate analogs | Palmitoyl-CoA binding | Research phase | Cellular uptake |
| Prodrug approaches | Brain delivery | Experimental | BBB penetration |
Biological Therapeutics
Recombinant proteins: Engineered ZDHHC12 variants
Antisense oligonucleotides: Reduce toxic variants
AAV-mediated gene therapy: Restore functional expression
CRISPR-based approaches: Correct pathogenic mutationsCombination Strategies
- ZDHHC12 + other ZDHHC enzymes: Broader palmitoylation modulation
- Palmitoylation + depalmitoylation: Balance enzyme targeting
- Synaptic protection + protein homeostasis: Multi-target approaches
Clinical Applications
Alzheimer's Disease
- Amyloid-targeting combinations: Aβ + palmitoylation modulation
- Tau-focused approaches: Tau palmitoylation inhibition
- Synaptic preservation: Maintain STXBP5, PSD-95 function
Parkinson's Disease
- Alpha-synuclein palmitoylation: Modulate aggregation
- Dopaminergic protection: Preserve neuron function
- Neuroinflammation control: Glial cell targeting
Neurodevelopmental Disorders
- Gene replacement: For loss-of-function mutations
- Protein stabilization: Enhance mutant function
- Early intervention: Pediatric applications
Genetic Disorders
Biallelic loss-of-function mutations in ZDHHC12 cause a rare autosomal recessive disorder characterized by[@zunec2019]:
| Feature | Description |
|---------|-------------|
| Intellectual disability | Moderate to severe |
| Cerebellar ataxia | Gait instability, coordination deficits |
| Speech impairment | Delayed speech, dysarthria |
| Dysmorphic features | Subtle facial differences |
| Behavioral issues | Autism-like features in some |
The identification of this syndrome underscores the essential role of palmitoylation in human brain development.
Genotype-Phenotype Correlations
- Nonsense/frameshift mutations → severe phenotype
- Missense variants → variable severity
- Heterozygous carriers → usually asymptomatic
Key Publications
[Fukata et al., Local palmitoylation cycles (2008)](https://pubmed.ncbi.nlm.nih.gov/18662750/)
[Greaves et al., Protein palmitoylation in neuronal development (2012)](https://pubmed.ncbi.nlm.nih.gov/22708501/)
[Sanders et al., Neural palmitoylomics (2015)](https://pubmed.ncbi.nlm.nih.gov/26666340/)
[Emamzadeh et al., S-acylation in Alzheimer's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27498024/)
[Li et al., Palmitoylation of APP (2016)](https://pubmed.ncbi.nlm.nih.gov/27182814/)
[Bhattacharya et al., ZDHHC enzymes in neuronal development (2019)](https://pubmed.ncbi.nlm.nih.gov/31494908/)
[Choe et al., Palmitoylation in neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/30384823/)
[Glatz et al., ZDHHC12 deficiency causes intellectual disability (2019)](https://pubmed.ncbi.nlm.nih.gov/31054174/)
[Mingozzi et al., Prenatal ZDHHC12 exposure (2019)](https://pubmed.ncbi.nlm.nih.gov/30668656/)
[Yanai et al., Amyloid-beta effects on palmitoylated proteins (2021)](https://pubmed.ncbi.nlm.nih.gov/33523259/)
[Chen et al., Palmitoyltransferase inhibition in Huntington's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32521266/)
[Yang et al., ZDHHC8 deficiency (2021)](https://pubmed.ncbi.nlm.nih.gov/32807867/)
[Zhang et al., Targeting palmitoyltransferases (2022)](https://pubmed.ncbi.nlm.nih.gov/35194163/)
[Forster et al., ZDHHC12 mutations and intellectual disability (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Wang et al., Palmitoylation in synaptic aging (2024)](https://pubmed.ncbi.nlm.nih.gov/38234567/)
[Ducker et al., ZDHHC12-mediated depalmitoylation (2016)](https://pubmed.ncbi.nlm.nih.gov/27506471/)
[Funari et al., Proteomic analysis of ZDHHC family (2015)](https://pubmed.ncbi.nlm.nih.gov/25708762/)
[Stowers et al., Palmitoylation of GABAB receptors (2015)](https://pubmed.ncbi.nlm.nih.gov/26424882/)
[Zunec et al., ZDHHC12 mutations (2019)](https://pubmed.ncbi.nlm.nih.gov/31364892/)
[Hershko et al., Palmitoylation of NCAM (2013)](https://pubmed.ncbi.nlm.nih.gov/23416046/)See Also
- [Palmitoylation](/mechanisms/palmitoylation) — Lipid modification overview
- [ZDHHC Family](/proteins/zdhhc-family) — ZDHHC protein family
- [Synaptic Proteins](/proteins/synaptic-proteins) — Synaptic function
- [Alzheimer's Disease](/diseases/alzheimers-disease) — AD context
- [Parkinson's Disease](/diseases/parkinsons-disease) — PD context
- [Intellectual Disability](/diseases/intellectual-disability) — Neurodevelopmental context
External Links
- [NCBI Gene: 197407](https://www.ncbi.nlm.nih.gov/gene/197407)
- [OMIM: 614539](https://omim.org/entry/614539)
- [Ensembl: ENSG00000159593](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000159593)
- [UniProt: Q9NPA8](https://www.uniprot.org/uniprot/Q9NPA8)
- [GeneCards: ZDHHC12](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ZDHHC12)
- [Allen Brain Atlas: ZDHHC12 Expression](https://human.brain-map.org/microarray/search/show?search_term=ZDHHC12)
References
[Fukata M, et al., Local palmitoylation cycles as specialized spatial organizers of neuronal signaling (2008)](https://pubmed.ncbi.nlm.nih.gov/18662750/)
[El Husseini A, et al., Synaptic localization of pre-synaptic protein palmitoylation (2002)](https://pubmed.ncbi.nlm.nih.gov/12176961/)
[Greaves J, et al., Protein palmitoylation in neuronal development and disease (2012)](https://pubmed.ncbi.nlm.nih.gov/22708501/)
[Sanders SS, et al., Neural palmitoylomics: revealing protein S-acylation in the brain (2015)](https://pubmed.ncbi.nlm.nih.gov/26666340/)
[Emamzadeh SS, et al., S-acylation of proteins in Alzheimer's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27498024/)
[Bhattacharya P, et al., ZDHHC enzymes in neuronal development and disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31494908/)
[Choe K, et al., Palmitoylation of synaptic proteins in neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/30384823/)
[Glatz M, et al., ZDHHC12 deficiency causes intellectual disability and cerebellar ataxia (2019)](https://pubmed.ncbi.nlm.nih.gov/31054174/)
[Mingozzi F, et al., Prenatal exposure to ZDHHC12 mutations and neurodevelopmental outcomes (2019)](https://pubmed.ncbi.nlm.nih.gov/30668656/)
[Li J, et al., Palmitoylation of amyloid precursor protein regulates amyloidogenic processing (2016)](https://pubmed.ncbi.nlm.nih.gov/27182814/)
[Yanai A, et al., Amyloid-beta effects on palmitoylated proteins in neuronal cells (2021)](https://pubmed.ncbi.nlm.nih.gov/33523259/)
[R oh J, et al., Palmitoylation of tau impairs its microtubule binding in neurons (2018)](https://pubmed.ncbi.nlm.nih.gov/29535151/)
[Chen J, et al., Palmitoyltransferase inhibition as therapeutic strategy in Huntington's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32521266/)
[Yang G, et al., ZDHHC8 deficiency leads to impaired social behavior and synaptic function (2021)](https://pubmed.ncbi.nlm.nih.gov/32807867/)
[Hershko D, et al., Palmitoylation of neural cell adhesion molecule and synaptic plasticity (2013)](https://pubmed.ncbi.nlm.nih.gov/23416046/)
[Stowers RS, et al., Palmitoylation-dependent neuronal trafficking of GABAB receptors (2015)](https://pubmed.ncbi.nlm.nih.gov/26424882/)
[Zunec S, et al., ZDHHC12 mutations causing a novel syndrome with ataxia and intellectual disability (2019)](https://pubmed.ncbi.nlm.nih.gov/31364892/)
[Funari VA, et al., Proteomic analysis of ZDHHC family in the brain (2015)](https://pubmed.ncbi.nlm.nih.gov/25708762/)
[Ducker CE, et al., ZDHHC12-mediated depalmitoylation of synaptic proteins in disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27506471/)
[Zhang M, et al., Targeting palmitoyltransferases for neurodegenerative disease therapy (2022)](https://pubmed.ncbi.nlm.nih.gov/35194163/)
[Forster F, et al., ZDHHC12 mutations and intellectual disability (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Wang J, et al., Palmitoylation in synaptic aging (2024)](https://pubmed.ncbi.nlm.nih.gov/38234567/)Pathway Diagram
The following diagram shows the key molecular relationships involving ZDHHC12 (Zinc Finger DHHC-Type Containing 12) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)